Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add filters








Language
Year range
1.
Clinics ; 70(2): 136-143, 2/2015. tab, graf
Article in English | LILACS | ID: lil-741419

ABSTRACT

OBJECTIVES: Seeds are excellent sources of proteinase inhibitors, some of which may have satietogenic and slimming actions. We evaluated the effect of a trypsin inhibitor from Tamarindus indica L. seeds on weight gain, food consumption and cholecystokinin levels in Wistar rats. METHODS: A trypsin inhibitor from Tamarindus was isolated using ammonium sulfate (30-60%) following precipitation with acetone and was further isolated with Trypsin-Sepharose affinity chromatography. Analyses were conducted to assess the in vivo digestibility, food intake, body weight evolution and cholecystokinin levels in Wistar rats. Histological analyses of organs and biochemical analyses of sera were performed. RESULTS: The trypsin inhibitor from Tamarindus reduced food consumption, thereby reducing weight gain. The in vivo true digestibility was not significantly different between the control and Tamarindus trypsin inhibitor-treated groups. The trypsin inhibitor from Tamarindus did not cause alterations in biochemical parameters or liver, stomach, intestine or pancreas histology. Rats treated with the trypsin inhibitor showed significantly elevated cholecystokinin levels compared with animals receiving casein or water. CONCLUSION: The results indicate that the isolated trypsin inhibitor from Tamarindus reduces weight gain by reducing food consumption, an effect that may be mediated by increased cholecystokinin. Thus, the potential use of this trypsin inhibitor in obesity prevention and/or treatment should be evaluated. .


Subject(s)
Humans , Escherichia coli Infections/epidemiology , Escherichia coli/enzymology , beta-Lactamases/metabolism , Escherichia coli/pathogenicity , Feces/microbiology
2.
Acta cir. bras ; 24(6): 460-465, Nov.-Dec. 2009. graf, tab
Article in English | LILACS | ID: lil-533207

ABSTRACT

PURPOSE: Evaluation of the rheological, biological and therapeutic properties of a new topical formulation consisting of chitosan gel containing 1 percent silver sulfadiazine, as an alternative for the treatment of burn wounds. METHODS: An experimental study was done with 21 Wistar rats divided into three groups. Group I was treated with chitosan gel without the antimicrobial, group II was treated with chitosan gel with 1 percent silver sulfadiazine and group III was treated with commercially available 1 percent silver sulfadiazine cream. RESULTS: Due to its pseudoplastic characteristic and good bioadhesiveness, the chitosan gels showed a satisfactory retention time over the wounds. No statistical difference was found in the amount of drug released from the chitosan gel and commercially available cream, as well as in the healing time among the groups. Wounds treated with chitosan gel with silver sulfadiazine showed a higher fibroblast production and a better angiogenesis than in the other groups, which are important parameters on the evolution of the healing process. CONCLUSION: The topical use of chitosan gel in association with silver sulfadiazine ameliorated the neovascularization and inflammatory reaction in burn wounds. This new formulation showed advantageous rheological properties and efficient release of the drug.


OBJETIVO: Avaliar as propriedades reológicas, biológicas e terapêuticas de uma nova formulação de uso tópico, a partir de um gel de quitosana, contendo sulfadiazina de prata a 1 por cento, no tratamento de queimaduras. MÉTODOS: Foi realizado estudo experimental com 21 ratos Wistar distribuídos em três grupos de sete animais. As queimaduras dos animais do grupo I foram tratadas com gel de quitosana sem antimicrobiano, o grupo II foi tratado com gel de quitosana contendo sulfadiazina de prata 1 por cento e o grupo III foi tratado com creme de sulfadiazina de prata 1 por cento, comumente utilizado no tratamento de queimados. RESULTADOS: Devido às características pseudoplásticas e à boa bioadesividade, os géis de quitosana apresentaram um tempo de retenção satisfatório sobre as feridas. A liberação da sulfadiazina de prata, bem como o tempo de cicatrização, não foram estatisticamente diferentes. Feridas tratadas com o gel de quitosana contendo sulfadiazina de prata apresentaram uma maior produção de fibroblastos e uma melhor angiogênese, comparando-se com os outros grupos, fatores que indicaram uma maior evolução no processo de cicatrização. CONCLUSÃO: O uso tópico do gel de quitosana com sulfadiazina de prata a 1 por cento melhorou a neovascularização e a reação inflamatória em queimaduras e essa nova formulação mostrou boas propriedades reológicas associadas a eficiente liberação do fármaco.


Subject(s)
Animals , Male , Rats , Burns/drug therapy , Chitosan/administration & dosage , Silver Sulfadiazine/administration & dosage , Wound Healing/drug effects , Administration, Topical , Burns/metabolism , Chitosan/chemistry , Gels , Models, Animal , Neovascularization, Physiologic/drug effects , Rats, Wistar , Rheology
SELECTION OF CITATIONS
SEARCH DETAIL